ACEPODIA Trademark

Trademark Overview


On Thursday, June 15, 2023, a trademark application was filed for ACEPODIA with the United States Patent and Trademark Office. The USPTO has given the ACEPODIA trademark a serial number of 98044259. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 11, 2024. This trademark is owned by Acepodia Biotechnologies Ltd.. The ACEPODIA trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for use in cell cultures for medical or therapeutic purposes; Biological tissue cultures for medical purposes; Medicinal preparations for the treatment and prevention of cancer, tumors, autoimmune disease, neuronal disease, hematopoietic cell-related disease, metabolic syndrome, infectious diseases, immune disease, inflammation and inflammatory diseases for human purposes; Drugs, namely, pharmaceuticals for the treatment and prevention of cancer, tumors, autoimmune disease, neuronal disease, hematopoietic cell-related disease, metabolic syndrome, infectious diseases, immune disease, inflammation and inflammatory diseases for medical purposes; Pharmaceutical preparations for the treatment and prevention of cancer, tumors, autoimmune disease, neuronal disease, hematopoietic cell-related disease, metabolic syndrome, infectious diseases, immune disease, inflammation and inflammatory diseases; Cells for clinical, medical, veterinary, or therapeutic purposes or use; C...
acepodia

General Information


Serial Number98044259
Word MarkACEPODIA
Filing DateThursday, June 15, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2024

Trademark Statements


Goods and ServicesBiological preparations for use in cell cultures for medical or therapeutic purposes; Biological tissue cultures for medical purposes; Medicinal preparations for the treatment and prevention of cancer, tumors, autoimmune disease, neuronal disease, hematopoietic cell-related disease, metabolic syndrome, infectious diseases, immune disease, inflammation and inflammatory diseases for human purposes; Drugs, namely, pharmaceuticals for the treatment and prevention of cancer, tumors, autoimmune disease, neuronal disease, hematopoietic cell-related disease, metabolic syndrome, infectious diseases, immune disease, inflammation and inflammatory diseases for medical purposes; Pharmaceutical preparations for the treatment and prevention of cancer, tumors, autoimmune disease, neuronal disease, hematopoietic cell-related disease, metabolic syndrome, infectious diseases, immune disease, inflammation and inflammatory diseases; Cells for clinical, medical, veterinary, or therapeutic purposes or use; Cell-derived preparations, namely, natural killer cell, gamma delta T cell, or other immune cell-derived preparations, for clinical, medical, veterinary, or therapeutic purposes; Therapeutic products derived from cells or cell-derived preparations, namely, natural killer cells, gamma delta T cell, and other immune cell, for clinical, medical, veterinary, or therapeutic purposes; Kits comprised of cells and reagents and also containing related instructions for clinical, medicinal, veterinary, or therapeutic purposes or use; Kits comprised of cell-derived preparations, namely, natural killer cell, gamma delta T cell, and other immune cell-derived preparations and reagents and also containing related instructions, for clinical, medicinal, veterinary, or therapeutic purposes or use; Gene therapy products, namely, genetically engineered cells for medical or clinical purposes or use; Pharmaceutical preparations, pharmaceutical products, therapeutic agents, and pharmaceuticals for targeting tissues based on select tissue markers and ligands, or for the purpose of binding ligands using engineered proteins and receptors; Pharmaceuticals, namely, pharmaceutical preparations, pharmaceutical products, therapeutic agents, and pharmaceuticals for use in the prevention and treatment of cancer, tumors, hematologic disease, solid cancers, hyperproliferative disease, autoimmune disease, neuronal diseases, hematopoietic cell-related diseases, metabolic syndrome, infectious diseases, immune disease or disorder, and inflammation and inflammatory diseases and in cellular transplants; Biotechnology and pharmaceutical products, namely, therapeutic cells, therapeutic peptide, therapeutic proteins, and therapeutic nucleic acids for human use for the treatment and prevention of cancer, tumors, autoimmune disease, a neuronal disease, a hematopoietic cell-related disease, metabolic syndrome, infectious diseases, immune disease, inflammation and inflammatory diseases; Pharmaceutical preparations or pharmaceutical products, namely, cell media for use in activating t-cells for use in adoptive t-cell therapy for the treatment of hematological and solid cancers; Pharmaceutical preparations, biological preparations, and therapeutic agents to modulate cell function or cell fate; Reagents for medical research, pharmaceutical drug discovery and development, pre-clinical, clinical, and medical use; Biological preparations and therapeutic agents used for medical cell therapy, adoptive immunotherapy, or other immunotherapy; Therapeutic cell preparation based on NK cells (natural killer cells), gamma delta T cell, other immune cell, or other cell for the treatment of cancer, tumors, neuronal diseases, hematopoietic cell-related diseases, metabolic syndrome, infectious diseases, auto-immune diseases, and inflammatory and immune disorders; Bio-engineered component for a therapeutic material, namely, cell lines based on NK cells (natural killer cells), gamma delta T cell, or other immune cell used for medical or clinical use used for immunotherapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 19, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAcepodia Biotechnologies Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Taipei City 22175
TW

Party NameAcepodia Biotechnologies Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Taipei City 22175
TW

Trademark Events


Event DateEvent Description
Friday, March 8, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, June 19, 2023NEW APPLICATION ENTERED
Wednesday, July 19, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 5, 2024ASSIGNED TO EXAMINER
Friday, March 8, 2024EXAMINERS AMENDMENT E-MAILED
Friday, March 8, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 8, 2024EXAMINER'S AMENDMENT ENTERED
Friday, March 8, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT